DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+16.43%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.68B
AUM Growth
+$4.68B
(+4.4%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
50.13%
Holding
123
New
17
Increased
19
Reduced
10
Closed
18
Top Buys
| 1 |
Apellis Pharmaceuticals
APLS
|
$28.5M |
| 2 |
AMED
Amedisys
AMED
|
$28.4M |
| 3 |
Revolution Medicines
RVMD
|
$24.7M |
| 4 |
Cabaletta Bio
CABA
|
$24.2M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$23M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$50.5M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
$48.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$39.7M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$36.6M |
| 5 |
Evolus
EOLS
|
$30.2M |
Sector Composition
| 1 | Healthcare | 68.03% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-1,831,607
| Closed | -$11.2M |
|
102
Krystal Biotech
KRYS
$4.35B
| – | – |
-311,949
| Closed | -$25M |
|
|
103
Mirum Pharmaceuticals
MIRM
$3.75B
| – | – |
-2,032,335
| Closed | -$48.8M |
|